|
|
|
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.
|
Gum PA, Kottke-Marchant K, Welsh PA et al.
|
|
J Am Coll Cardiol 2003;41:961-5.
|
|
|
|
|
Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery.
|
Oates-Whitehead RM, D'Angelo A, Mol B.
|
|
Cochrane Database Syst Rev 2003;(4):CD003679.
|
|
|
|
|
Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.
|
Andre P, LaRocca T, Delaney SM, et al.
|
|
Circulation 2003;108:2697-703. Epub 2003 Nov 03.
|
|
|
|
|
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
|
Chen WH, Lee PY, Ng W, et al.
|
|
J Am Coll Cardiol 2004;43:1122-6.
|
|
|
|
|
Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences.
|
Viles-Gonzalez JF, Fuster V, Badimon JJ.
|
|
Eur Heart J 2004;25:1197-207.
|
|
|
|
|
Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
|
Payne DA, Jones CI, Hayes PD et al.
|
|
Circulation 2004;109:1476-81. Epub 2004 Mar 08.
|
|
|
|
|
Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
|
Payne DA, Jones CI, Hayes PD et al.
|
|
Circulation 2004;109:1476-81. Epub 2004 Mar 08.
|
|
|
|
|
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke 2004;35:533-7.
|
Zakarija A, Bandarenko N, Pandey DK et al.
|
|
Stroke 2004;35:533-7. Epub 2004 Jan 05.
|
|
|
|
|
Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting.
|
Manor SM, Guillory GS, Jain SP.
|
|
Pharmacotherapy 2004;24:664-7.
|
|
|
|
|
Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation.
|
Amorosi SL, Tsilimingras K, Thompson D, et al.
|
|
Am J Cardiol 2004;93:509-11.
|
|
|
|
|
Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study.
|
Perrier A, Roy PM, Aujesky D, et al.
|
|
Am J Med 2004;116:291-9.
|
|
|
|
|
Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting.
|
Weltermann A, Fritsch P, Kyrle PA, et al.
|
|
Thromb Res 2003;112:19-24.
|
|
|
|
|
Efficacy and safety of low-dose aspirin in polycythemia vera.
|
Landolfi R, Marchioli R, Kutti J, et al.
|
|
N Engl J Med 2004;350:114-24.
|
|
|
|
|
Enoxaparin versus tinzaparin in non-ST-segment elevation acute coronary syndromes: the EVET trial.
|
Michalis LK, Katsouras CS, Papamichael N, et al.
|
|
Am Heart J 2003;146:304-10.
|
|
|
|
|
Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.
|
Sabatine MS, McCabe CH, Morrow DA, et al.
|
|
Am Heart J 2002;143:966-70.
|
|
|
|
|
Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
|
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al.
|
|
J Invasive Cardiol 2004;16:325-9.
|
|
|
|
|
Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
|
Lepantalo A, Virtanen KS, Heikkila J, et al.
|
|
Eur Heart J 2004;25:476-83.
|
|
|
|
|
Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy.
|
Jafri SM.
|
|
Am Heart J 2004;147:3-15.
|
|
|
|
|
Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).
|
Eagle KA, Goodman SG, Avezum A, et al.
|
|
Lancet 2002;359:373-7.
|
|
|
|
|
Pulmonary embolism.
|
Goldhaber SZ.
|
|
Lancet 2004;363:1295-305.
|
|
|
|
|
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
|
Samama MM, Dahl OE, Quinlan DJ, et al.
|
|
Haematologica 2003;88:1410-21.
|
|
|
|
|
Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
|
Kleber FX, Witt C, Vogel G,
|
|
Am Heart J 2003;145:614-21.
|
|
|
|
|
Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms.
|
Macchi L, Christiaens L, Brabant S, et al.
|
|
J Am Coll Cardiol 2003;42:1115-9.
|
|
|
|
|
Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice.
|
McGarry LJ, Thompson D.
|
|
Clin Ther 2004;26:419-30.
|
|
|
|
|
Risk factors for venous
thromboembolism in hospitalized patients with acute
medical illness: analysis of the MEDENOX Study.
|
Alikhan R, Cohen AT, Combe S, et al.
|
|
Arch Intern Med 2004;164:963-8.
|
|
|
|
|
Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
|
Orford JL, Fasseas P, Melby S, et al.
|
|
Am Heart J 2004;147:463-7.
|
|
|
|
|
The skinny on treatment of venous thromboembolism in obesity
|
Spinler SA.
|
|
J Thromb Haemost. 2005 May;3(5):854-5.
|
|